JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 18, 2006; DOI: 10.1124/jpet.105.097642


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.105.097642v1
318/2/579    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrew D. Miller
Natalia Lozovaya
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melnik, S.
Right arrow Articles by Lozovaya, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melnik, S.
Right arrow Articles by Lozovaya, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
*NITROGLYCERIN


Received for publication November 18, 2005.
Revised May 17, 2006.
Accepted for publication May 17, 2006.

Diadenosine polyphosphate analogue controls postsynaptic exitation in CA3-CA1 synapses via a nitric oxide (NO) -dependent mechanism

Sergei Melnik 1, Michael Wright 2, Julian A. Tanner 2, Timur Tsintsadze 1, Vera Tsintsadze 1, Andrew D. Miller 2, Natalia Lozovaya 3*

1 Department of Cellular Membranology, Bogomoletz Institute of Physiology, Kiev, Ukraine 2 Imperial College Genetic Therapies Centre, Department of Chemistry, London , UK 3 Bogomoletz Institute of physiology

* Address correspondence to: E-mail: n_lozovaya{at}yahoo.com

Abstract

Previously, we have described the modulatory effect of diadenosine polyphosphates Ap4A and Ap5A on synaptic transmission in the rat hippocampal slices, mediated by presynaptic receptors (Klishin et al., 1994). In contrast, we now describe how non-hydrolysable Ap4A analogue diadenosine-5',5'"-P1,P4-[{beta},{beta}'-methylene]tetraphosphate (AppCH2ppA) at low µM concentrations exerts strong non-desensitizing inhibition of orthodromically evoked field potentials (OFPs), without affecting the amplitude of excitatory postsynaptic currents (EPSCs) and antidromically evoked field potentials (AFPs), as recorded in hippocampal CA1 zone. The effects of AppCH2ppA on OFPs are eliminated by a P2 receptor antagonist PPADS but not mimicked by purinoceptor agonists, {alpha},{beta}-methylene-ATP and ATP-{gamma}-S, indicating that a P2-like receptor is involved but not one belonging to the conventional P2X/P2Y receptor classes. Diadenosine polyphosphate receptor (P4) antagonist, Ip4I, was unable to modulate AppCH2ppA effects. Thus, the PPADS-sensitive P2-like receptor for AppCH2ppA appears to control selectively dendritic excitation of the CA1 neurons. The specific nitric oxide (NO)-scavenger 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (PTIO) is shown to attenuate significantly AppCH2ppA mediated inhibitory effects, indicating that NO is involved in the cascade of events initiated by AppCH2ppA. Further downstream mediation by adenosine A1 receptors is also demonstrated. Hence, AppCH2ppA-mediated effects involve PPADS-sensitive P2-like receptor activation leading to the production of NO that stimulates intracellular synthesis of adenosine, causing in turn postsynaptic A1 receptor activation and subsequent postsynaptic CA1 dendritic inhibition. Such spatially selective postsynaptic dendritic inhibition may influence dendritic electrogenesis in pyramidal neurons and consequently mediate control of neuronal network activity.


Key words: Diadenosine polyphosphate analogue, adenosine A1 receptors, hippocampus, nitric oxide, purine receptors, synaptic transmission





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.